ShockWave Medical stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 77 to 89.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique RS Rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the best stocks typically have an RS Rating north of 80 in the early stages of their moves.
Looking For Winning Stocks? Try This Simple Routine
Is ShockWave Medical Stock A Buy?
ShockWave Medical stock coming up from a first stage cup-with-handle base pattern, showing a potential entry point of 223.25. See if the stock goes on to form a sound pattern that could ignite a new run. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
Earnings growth rose last quarter from 0% to 157%, but revenue fell from 271% to 194%.
ShockWave Medical stock holds the No. 3 rank among its peers in the Medical-Systems/Equipment industry group. ShockWave Medical and Steris are also among the group's highest-rated stocks.
